EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Effective Sublingual Vaccine, MV140, Safely Reduces Risk of Recurrent Urinary Tract Infection in Women

J Curtis Nickel iD, R Christopher Doiron

Pathogens · 21.02.2023 · 12 (3) · 359

DOI: 10.3390/pathogens12030359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 21.02.2023. Verfasst von J Curtis Nickel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Queen's University, Kingston, ON K7L 3N6, Canada. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inmunotek, Madrid, Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uncomplicated recurrent urinary tract infections (rUTIs) in women are associated with episodic bothersome symptoms and have a significant impact on the mental and physical quality of life. Treatment with antibiotics (short- and long-term dosing) results in acute and chronic side effects and costs and promotes general antibiotic resistance. Improved nonantibiotic management of rUTI in women represents a true, unmet medical need. MV140 is a novel sublingual mucosal-based bacterial vaccine developed for the prevention of rUTI in women. Based on observational, prospective, and randomized placebo-controlled studies, MV140 has been shown to safely prevent (or reduce the risk of) UTIs, reduce antibiotic use, overall management costs, and patient burden while improving the overall quality of life in women suffering from rUTIs.

Schlagwörter

Stichwörter der Autor:innen

recurrent urinary tract infectionsurinary tract infectionsvaccinewomen’s health

Autor:innen und Institutionen

  • Department of Urology, Queen's University, Kingston, ON K7L 3N6, Canada.

ORCID-Profile: J Curtis Nickel

Förderung

  • Inmunotek, Madrid, Spain

Zitieren

APA

Nickel, J. C., & Doiron, R. C. (2023). An Effective Sublingual Vaccine, MV140, Safely Reduces Risk of Recurrent Urinary Tract Infection in Women. Pathogens, 12(3), 359. https://doi.org/10.3390/pathogens12030359

Vancouver

Nickel JC, Doiron RC. An Effective Sublingual Vaccine, MV140, Safely Reduces Risk of Recurrent Urinary Tract Infection in Women. Pathogens. 2023;12(3):359. doi:10.3390/pathogens12030359

BibTeX
@article{Nickel2023,
  author = {Nickel, J Curtis and Doiron, R Christopher},
  title = {An Effective Sublingual Vaccine, MV140, Safely Reduces Risk of Recurrent Urinary Tract Infection in Women},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {359},
  doi = {10.3390/pathogens12030359}
}
Kostenlos starten →